The Global CIS Insulin Industry is on track to achieve a significant milestone, with a projected valuation of US$ 600 Million by 2032, as per the latest insights unveiled by FMI. The industry has demonstrated steady growth, securing US$ 465 Million in 2022 and reflecting a notable 2.2% Compound Annual Growth Rate (CAGR) from 2015 …